Psychedelic stocks = super-risky biotechs low on cash. Make small bets.
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Analyst https://seekingalpha.com/author/alexander-carchidi?source=cip_podcast:psychedelic_stocks_super_risky_biotechs_low_on_cash returns to update investors on the psychedelics industry. This is the full conversation of an interview originally published on https://seekingalpha.com/article/4616920-psychedelic-stocks-dont-bet-on-just-1-company?source=cip_podcast:psychedelic_stocks_super_risky_biotechs_low_on_cash. - (2:50) Industry's collapse and consolidation - (5:00)...
show more- (2:50) Industry's collapse and consolidation
- (5:00) Compass Pathways timeline for clinical trials
- (15:00) Super-risky biotech companies low on cash - don't bet on just 1 company
- (21:20) Atai and Cybin's recent wins
- (32:55) Ketamine clinics and viable business models
Cybin: A Leading Early-Stage Psychedelics Play
Psychedelic Sunday: Mushrooms Are The Key - Red Light Holland CEO Todd Shapiro
Numinus CEO Payton Nyquvest On Transforming Healthcare With Psychedelics
Podcast transcripts on Seeking Alpha
Cannabis Investing Podcast Twitter
Information
Author | Seeking Alpha |
Organization | Seeking Alpha |
Website | seekingalpha.com |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comments